SCHEMBL1065866

SCHEMBL1065866

C/C=C(\C)C(O)OP(=O)(OC(O)/C(C)=C/C)OP(=O)(OC(O)/C(C)=C/C)OC(O)/C(C)=C/C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724326 1.00
SCHEMBL5068306 0.79 SMPD1 (0.32)
SCHEMBL5059478 0.79 SMPD1 (0.32)
SCHEMBL5059477 0.77 BTN3A1 (0.40)
SCHEMBL5064882 0.77 BTN3A1 (0.40)
SCHEMBL2585100 0.68
SCHEMBL4301895 0.68
SCHEMBL3628442 0.61 CTSA (0.50)
SCHEMBL14941406 0.57 ALDH1A1 (0.33)
SCHEMBL22367758 0.57 CTSA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013071074-A1 METHODS OF PRODUCING BUTADIENE INVISTA NORTH AMERICA S.A. R.L. (US) 2013-05-16 WO claimed
WO-2011034397-A2 METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES 한국과학기술원 (KR) 2011-03-24 WO claimed
US-20080318227-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway BACHER ADELBERT 2008-12-25 US claimed
US-7297509-B2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway Bacher, Adelbert (DE) 2007-11-20 US claimed
US-20040176570-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway ROHDICH, FELIX (DE) 2004-09-09 US claimed
EP-1377663-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2004-01-07 EP claimed
WO-2002083720-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2002-10-24 WO claimed
US-20240018559-A1 GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS ACIES BIO D.O.O. (SI) 2024-01-18 US disclosed
EP-4251745-A1 GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS Acies Bio d.o.o. (SI) 2023-10-04 EP disclosed
CN-116745410-A Genetically engineered bacteria capable of producing cytokinins with isoprenoid side chains 阿西耶斯生物公司 2023-09-12 CN disclosed
WO-2022112509-A1 GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS ACIES BIO D.O.O. (SI) 2022-06-02 WO disclosed
EP-4006139-A1 GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS Acies Bio d.o.o. (SI) 2022-06-01 EP disclosed
US-20210153484-A1 Humanized Mouse Model The Wistar lnstitute (US) 2021-05-27 US disclosed
US-20040176570-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway ROHDICH, FELIX (DE) 2004-09-09 US disclosed
WO-2004050096-A2 PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE INNATE PHARMA (FR) 2004-06-17 WO disclosed
EP-1377663-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2004-01-07 EP disclosed
EP-1377663-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2004-01-07 EP disclosed
WO-2002083720-A3 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2003-08-28 WO disclosed
WO-2002083720-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2002-10-24 WO disclosed
WO-2002083720-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2002-10-24 WO disclosed